Global Oral Biologics Market
According to Intent Market Research, the Oral Biologics Market is expected to grow from USD 2.2 Billion in 2024-e at a CAGR of 25.8% to touch USD 8.8 Billion by 2030. The Oral Biologics Market is dominated by key players such as Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and Eli Lilly and Company.